Indicateurs
1 Consultations de la notice
- Titre
- Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib
- Créateurs - sans rôle
- Bernard Combe - Rheumatology, CHU Montpellier, Montpellier University, Montpellier, FranceAlejandro Balsa - Hospital Universitario La PazPiercarlo Sarzi-Puttini - L Sacco University Hospital, Milan, ItalyHans-Peter Tony - University Hospital of Würzburg, Würzburg, GermanyInmaculada de la Torre - Eli Lilly and Company, Indianapolis, Indiana, USAVeronica Rogai - Eli Lilly and Company, Indianapolis, Indiana, USAFrederick Durand - Eli Lilly and Company, Indianapolis, Indiana, USASarah Witt - Eli Lilly and Company, Indianapolis, Indiana, USAJinglin Zhong - IQVIA, North Carolina, North Carolina, USAMaxime Dougados - René Descartes University, Hôpital Cochin, Paris, France
- Détails de publication
- Annals of the rheumatic diseases, Vol.78(8), p.1135-1138
- Identifiants
- 99233924509311
- Unité académique
- IGMM - Institut de Génétique Moléculaire de Montpellier
- Langue
- Anglais
- Type de ressource
- Article de revue scientifique